TY - JOUR T1 - Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. JF - Proc Natl Acad Sci U S A Y1 - 2008 A1 - Zhang, Lin A1 - Volinia, Stefano A1 - Bonome, Tomas A1 - Calin, George Adrian A1 - Greshock, Joel A1 - Yang, Nuo A1 - Liu, Chang-Gong A1 - Giannakakis, Antonis A1 - Alexiou, Pangiotis A1 - Hasegawa, Kosei A1 - Johnstone, Cameron N A1 - Megraw, Molly S A1 - Adams, Sarah A1 - Lassus, Heini A1 - Huang, Jia A1 - Kaur, Sippy A1 - Liang, Shun A1 - Sethupathy, Praveen A1 - Leminen, Arto A1 - Simossis, Victor A A1 - Sandaltzopoulos, Raphael A1 - Naomoto, Yoshio A1 - Katsaros, Dionyssios A1 - Gimotty, Phyllis A A1 - DeMichele, Angela A1 - Huang, Qihong A1 - Bützow, Ralf A1 - Rustgi, Anil K A1 - Weber, Barbara L A1 - Birrer, Michael J A1 - Hatzigeorgiou, Artemis G A1 - Croce, Carlo M A1 - Coukos, George KW - DNA, Neoplasm KW - Down-Regulation KW - Epigenesis, Genetic KW - Epithelial Cells KW - Female KW - Gene Expression Profiling KW - Gene Expression Regulation, Neoplastic KW - Genome, Human KW - Humans KW - MicroRNAs KW - Neoplasm Staging KW - Ovarian Neoplasms KW - Ribonuclease III KW - RNA, Messenger KW - Survival Analysis AB -

MicroRNAs (miRNAs) are an abundant class of small noncoding RNAs that function as negative gene regulators. miRNA deregulation is involved in the initiation and progression of human cancer; however, the underlying mechanism and its contributions to genome-wide transcriptional changes in cancer are still largely unknown. We studied miRNA deregulation in human epithelial ovarian cancer by integrative genomic approach, including miRNA microarray (n = 106), array-based comparative genomic hybridization (n = 109), cDNA microarray (n = 76), and tissue array (n = 504). miRNA expression is markedly down-regulated in malignant transformation and tumor progression. Genomic copy number loss and epigenetic silencing, respectively, may account for the down-regulation of approximately 15% and at least approximately 36% of miRNAs in advanced ovarian tumors and miRNA down-regulation contributes to a genome-wide transcriptional deregulation. Last, eight miRNAs located in the chromosome 14 miRNA cluster (Dlk1-Gtl2 domain) were identified as potential tumor suppressor genes. Therefore, our results suggest that miRNAs may offer new biomarkers and therapeutic targets in epithelial ovarian cancer.

VL - 105 IS - 19 ER - TY - JOUR T1 - microRNAs exhibit high frequency genomic alterations in human cancer. JF - Proc Natl Acad Sci U S A Y1 - 2006 A1 - Zhang, Lin A1 - Huang, Jia A1 - Yang, Nuo A1 - Greshock, Joel A1 - Megraw, Molly S A1 - Giannakakis, Antonis A1 - Liang, Shun A1 - Naylor, Tara L A1 - Barchetti, Andrea A1 - Ward, Michelle R A1 - Yao, George A1 - Medina, Angelica A1 - O'brien-Jenkins, Ann A1 - Katsaros, Dionyssios A1 - Hatzigeorgiou, Artemis A1 - Gimotty, Phyllis A A1 - Weber, Barbara L A1 - Coukos, George KW - Breast Neoplasms KW - Female KW - Gene Dosage KW - Gene Expression Profiling KW - Humans KW - MicroRNAs KW - Neoplasms KW - Nucleic Acid Hybridization KW - Oligonucleotide Array Sequence Analysis KW - Ovarian Neoplasms KW - Statistics as Topic AB -

MicroRNAs (miRNAs) are endogenous noncoding RNAs, which negatively regulate gene expression. To determine genomewide miRNA DNA copy number abnormalities in cancer, 283 known human miRNA genes were analyzed by high-resolution array-based comparative genomic hybridization in 227 human ovarian cancer, breast cancer, and melanoma specimens. A high proportion of genomic loci containing miRNA genes exhibited DNA copy number alterations in ovarian cancer (37.1%), breast cancer (72.8%), and melanoma (85.9%), where copy number alterations observed in >15% tumors were considered significant for each miRNA gene. We identified 41 miRNA genes with gene copy number changes that were shared among the three cancer types (26 with gains and 15 with losses) as well as miRNA genes with copy number changes that were unique to each tumor type. Importantly, we show that miRNA copy changes correlate with miRNA expression. Finally, we identified high frequency copy number abnormalities of Dicer1, Argonaute2, and other miRNA-associated genes in breast and ovarian cancer as well as melanoma. These findings support the notion that copy number alterations of miRNAs and their regulatory genes are highly prevalent in cancer and may account partly for the frequent miRNA gene deregulation reported in several tumor types.

VL - 103 IS - 24 ER -